CHARLES THEUER
CIK 1631338 · PRESIDENT AND CEO · last filed 2025-12-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$368.1K
Companies
3
Total Filings
68
Lifetime Open-Market Net
$694.3K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FDMT | Director | 41,684 | $8.83 | $368.1K | $0 | 6 | 2025-12-16 |
| Oncternal Therapeutics, Inc. (ONCT) Delisted | Director | 14,677 | $0.53 | $7.7K | $0 | 9 | 2024-06-24 |
| Tracon Pharmaceuticals, Inc. (TCON) Delisted | PRESIDENT AND CEO | 402,917 | $0.03 | $13.0K | $694.3K | 42 | 2024-03-13 |
Recent Filings · Page 7 of 7
68 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-02-23 | — | Grant (A) | — | $0 | |
| 2018-01-23 | — | Tax (F) | −9,290 | -$27.4K | |
| 2017-01-24 | — | Mixed | −9,870 | -$47.9K | |
| 2016-01-25 | — | Grant (A) | +90,900 | $0 | |
| 2015-09-22 | — | Mixed | — | -$166.4K | |
| 2015-09-14 | — | Sell (S) | −3,516 | -$42.2K | |
| 2015-08-18 | — | Sell (S) | −100 | -$1.2K | |
| 2015-03-30 | — | Grant (A) | — | $0 |
Showing 61–68 of 68
Prev
Page 7 of 7
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.